SLC13A3 Antikörper (C-Term)
Kurzübersicht für SLC13A3 Antikörper (C-Term) (ABIN927962)
Target
Alle SLC13A3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- SLC13 A3 antibody was raised in rabbit using the C terminal of SLC13 3 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
SLC13A3 Blocking Peptide, (ABIN938810), is also available for use as a blocking control in assays to test for specificity of this SLC13A3 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SLC13A3 (Solute Carrier Family 13 Member 3 (SLC13A3))
-
Andere Bezeichnung
- SLC13A3
-
Hintergrund
- Mammalian sodium-dicarboxylate cotransporters transport succinate and other Krebs cycle intermediates. They fall into 2 categories based on their substrate affinity: low affinity and high affinity. Both the low- and high-affinity transporters play an important role in the handling of citrate by the kidneys. SLC13A3 represents the high-affinity form. Synonyms: Polyclonal SLC13A3 antibody, Anti-SLC13A3 antibody, solute carrier family 13, sodium-dependent dicarboxylate transporter, member 3 antibody, NADC3 antibody, SDCT2 antibody.
-
Pathways
- Dicarboxylic Acid Transport
Target
-